Recursion Pharmaceuticals amasses $121 mln Series C
Salt Lake City-based Recursion Pharmaceuticals, a next-gen biopharma company, has secured $121 million in Series C financing. Baillie Gifford’s flagship investment trust Scottish Mortgage Investment Trust PLC led the round.
16 July 2019•1 min read
